Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)-Reference-Cited by-同舟云学术

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

Published:2020-09 Issue:9 Volume:127 Page:1201-1210
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Glassman Adam R.,Wells John A.,Josic Kristin^ORCID,Maguire Maureen G.,Antoszyk Andrew N.,Baker Carl^ORCID,Beaulieu Wesley T.,Elman Michael J.,Jampol Lee M.,Sun Jennifer K.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Ophthalmology

Reference13 articles.

1. Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE;Nguyen;Ophthalmology,2012

2. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Ophthalmology,2010

3. Intravitreal aflibercept for diabetic macular edema;Korobelnik;Ophthalmology,2014

4. Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States;Ciulla;Ophthalmol Retina,2018

5. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema;Wells;N Engl J Med,2015

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic retinopathy: New concepts of screening, monitoring, and interventions;Survey of Ophthalmology;2024-11

2. CST3 alleviates retinal vascular leakage by regulating the Rap1 signaling pathway;Experimental Eye Research;2024-10

3. Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group;European Journal of Ophthalmology;2024-09-05

4. Résultats anatomiques et fonctionnels du protocole thérapeutique « 3 + PRN » dans le traitement de l’œdème maculaire diabétique;Journal Français d'Ophtalmologie;2024-09

5. One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity;Ophthalmology Retina;2024-09